We are live on ! Find out more
BOLD

Boundless Bio

44 hedge funds and large institutions have $9.88M invested in Boundless Bio in 2025 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 7 increasing their positions, 19 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

19% less funds holding

Funds holding: 5444 (-10)

32.38% less ownership

Funds ownership: 76.11%43.72% (-32%)

48% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 21

63% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 19

98% less capital invested

Capital invested by funds: $419M → $9.88M (-$409M)

Holders
44
Holders Change
-10
Holders Change %
-18.52%
% of All Funds
0.58%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
11
Increased
7
Reduced
19
Closed
21
Calls
Puts
Net Calls
Net Calls Change

BOLD Hedge Fund Activity: Q2 2025 in Review

44 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Boundless Bio (BOLD) for Q2 2025, worth a combined $9.88M — down 98% from $419M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of BOLD and 11 opened new positions — a net loss of 10 holders — while 19 trimmed existing stakes and 7 added.

The largest buyer was Millennium Management, opening a new position worth an estimated $284K. The largest seller was Nuveen, exiting entirely with an estimated $399M sold.

  • 44 institutional investors held Boundless Bio (BOLD) as of Q2 2025, down from 54 in Q1 2025.
  • Funds reported $9.88M of Boundless Bio stock for Q2 2025, down 98% quarter-over-quarter.
  • 11 funds opened new Boundless Bio positions in Q2 2025 and 21 closed out, a net change of -10 holders.
  • The largest Boundless Bio buyer in Q2 2025 was Millennium Management, an estimated $284K added.
  • The largest Boundless Bio seller in Q2 2025 was Nuveen, an estimated $399M sold.

Based on aggregated 13F filings for Q2 2025.